Table of Content


Executive Summary
Scope and Definition

1 Markets
1.1 Trends: Current and Future Impact Assessment
1.1.1 Increasing Strategic Partnerships and Alliances between Market Players
1.1.2 Expanding Applications in NIPT Products
1.2 Supply Chain Overview
1.3 Research and Development Review
1.3.1 Patent Filing Trend (by Country, Year)
1.4 Regulatory Landscape
1.4.1 Regulatory Scenario in the U.S.
1.4.2 Regulatory Scenario in Canada
1.4.3 Regulatory Scenario in the U.K.
1.4.4 Regulatory Scenario in Germany
1.4.5 Regulatory Scenario in France
1.4.6 Regulatory Scenario in Spain
1.4.7 Regulatory Scenario in Italy
1.4.8 Regulatory Scenario in the Netherlands
1.4.9 Regulatory Scenario in China
1.4.10 Regulatory Scenario in India
1.4.11 Regulatory Scenario in Australia
1.4.12 Regulatory Scenario in Japan
1.5 Reimbursement Scenario
1.6 Market Dynamics Overview
1.6.1 Market Drivers
1.6.1.1 High Incidence of Genetic Disorders
1.6.1.2 Rising Maternal Age
1.6.1.3 Increasing Number of Reimbursement Policies toward Genetic Coverage
1.6.1.4 Increased Emphasis on Early Detection and Prevention
1.6.2 Market Restraints
1.6.2.1 Stringent Regulatory Guidelines and Ethical Hurdles
1.6.2.2 Lack of Awareness Regarding NIPT
1.6.2.3 Limitations and Considerations in Non-Invasive Prenatal Testing
1.6.3 Market Opportunities
1.6.3.1 Leveraging the Opportunities Arising from the Growing Markets in Asia
1.6.3.2 Increasing Focus on Non-Invasive Pre-Implantation Genetic Testing (niPGT)

2 Application
2.1 Application Segmentation
2.2 Application Summary
2.2.1 Application Summary
2.2.2 End User Summary
2.3 Global Non-Invasive Prenatal Testing Market (by Application)
2.3.1 Trisomy Detection
2.3.2 Microdeletion Detection
2.3.3 Sex Chromosome Aneuploidy Detection
2.3.4 Others
2.4 Global Non-Invasive Prenatal Testing Market (by End User)
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Diagnostic Labs
2.4.4 Others

3 Products
3.1 Product Segmentation
3.2 Product Summary
3.2.1 Test Summary
3.2.2 Platform Summary
3.2.3 Method Summary
3.3 Global Non-Invasive Prenatal Testing Market (by Test)
3.3.1 Panorama and Vistara
3.3.2 MaterniT GENOME, MaterniT21 PLUS, and informaSeq
3.3.3 Verifi and Verifi Plus Prenatal Tests
3.3.4 NIFTY Test and NIFTY-Test Oro
3.3.5 QNatal Advanced
3.3.6 PrenaTest, GenaSafe, and PrenatalSAFE
3.3.7 Bambini Test
3.3.8 IONA and Sage
3.3.9 Other Harmony Test
3.4 Global Non-Invasive Prenatal Testing Market (by Method)
3.4.1 cfDNA
3.4.2 FCMB
3.5 Global Non-Invasive Prenatal Testing Market (by Platform)
3.5.1 NGS
3.5.2 PCR
3.5.3 Others

4 Regions
4.1 Drivers and Restraints
4.2 Regional Summary
4.3 North America
4.3.1 Regional Overview
4.3.2 Driving Factors for Market Growth
4.3.3 Factors Challenging the Market
4.3.4 Application
4.3.5 Product
4.3.6 U.S.
4.3.7 Canada
4.4 Europe
4.4.1 Regional Overview
4.4.2 Driving Factors for Market Growth
4.4.3 Factors Challenging the Market
4.4.4 Application
4.4.5 Product
4.4.6 France
4.4.7 Germany
4.4.8 U.K.
4.4.9 Spain
4.4.10 Italy
4.4.11 Rest-of-Europe
4.5 Asia-Pacific
4.5.1 Regional Overview
4.5.2 Driving Factors for Market Growth
4.5.3 Factors Challenging the Market
4.5.4 Application
4.5.5 Product
4.5.6 China
4.5.7 India
4.5.8 Japan
4.5.9 Rest-of-Asia-Pacific
4.6 Latin America
4.6.1 Regional Overview
4.6.2 Driving Factors for Market Growth
4.6.3 Factors Challenging the Market
4.6.4 Application
4.6.5 Product
4.6.6 Brazil
4.6.7 Mexico
4.6.8 Rest-of-Latin America
4.7 Middle East and Africa
4.7.1 Regional Overview
4.7.2 Driving Factors for Market Growth
4.7.3 Factors Challenging the Market
4.7.4 Application
4.7.5 Product
4.7.6 U.A.E.
4.7.7 South Africa
4.7.8 Rest-of-Middle East and Africa

5 Markets - Competitive Benchmarking & Company Profiles
5.1 Next Frontiers
5.2 Competitive Landscape
5.2.1 Agilent Technologies, Inc.
5.2.1.1 Overview
5.2.1.2 Product Portfolio
5.2.1.3 Top Competitors
5.2.1.4 Key Personnel
5.2.1.5 Target Customers
5.2.1.6 Analyst View
5.2.2 F. Hoffmann-La Roche Ltd
5.2.2.1 Overview
5.2.2.2 Product Portfolio
5.2.2.3 Top Competitors
5.2.2.4 Target Customers
5.2.2.5 Key Personnel
5.2.2.6 Analyst View
5.2.3 PerkinElmer, Inc.
5.2.3.1 Overview
5.2.3.2 Product Portfolio
5.2.3.3 Top Competitors
5.2.3.4 Target Customers
5.2.3.5 Key Personnel
5.2.3.6 Analyst View
5.2.4 Quest Diagnostics Incorporated
5.2.4.1 Overview
5.2.4.2 Product Portfolio
5.2.4.3 Top Competitors
5.2.4.4 Target Customers
5.2.4.5 Key Personnel
5.2.4.6 Analyst View
5.2.5 Illumina, Inc.
5.2.5.1 Overview
5.2.5.2 Product Portfolio
5.2.5.3 Top Competitors
5.2.5.4 Target Customers
5.2.5.5 Key Personnel
5.2.5.6 Analyst View
5.2.6 Myriad Genetics, Inc.
5.2.6.1 Overview
5.2.6.2 Product Portfolio
5.2.6.3 Top Competitors
5.2.6.4 Target Customers
5.2.6.5 Key Personnel
5.2.6.6 Analyst View
5.2.7 BGI Genomics
5.2.7.1 Overview
5.2.7.2 Product Portfolio
5.2.7.3 Top Competitors
5.2.7.4 Target Customers
5.2.7.5 Key Personnel
5.2.7.6 Analyst View
5.2.8 CENTOGENE N.V.
5.2.8.1 Overview
5.2.8.2 Product Portfolio
5.2.8.3 Top Competitors
5.2.8.4 Target Customers
5.2.8.5 Key Personnel
5.2.8.6 Analyst View
5.2.9 Laboratory Corporation of America Holdings
5.2.9.1 Overview
5.2.9.2 Product Portfolio
5.2.9.3 Top Competitors
5.2.9.4 Target Customers
5.2.9.5 Key Personnel
5.2.9.6 Analyst View
5.2.10 MedGenome Inc.
5.2.10.1 Overview
5.2.10.2 Product Portfolio
5.2.10.3 Top Competitors
5.2.10.4 Target Customers
5.2.10.5 Key Personnel
5.2.10.6 Analyst View
5.2.11 Annoroad Gene Technology
5.2.11.1 Overview
5.2.11.2 Product Portfolio
5.2.11.3 Top Competitors
5.2.11.4 Target Customers
5.2.11.5 Key Personnel
5.2.11.6 Analyst View
5.2.1 Natera, Inc.
5.2.1.1 Overview
5.2.1.2 Product Portfolio
5.2.1.3 Top Competitors
5.2.1.4 Target Customers
5.2.1.5 Key Personnel
5.2.1.6 Analyst View
5.2.2 Yourgene Health
5.2.2.1 Overview
5.2.2.2 Product Portfolio
5.2.2.3 Top Competitors
5.2.2.4 Target Customers
5.2.2.5 Key Personnel
5.2.2.6 Analyst View
5.2.3 Eurofins Scientific SE
5.2.3.1 Overview
5.2.3.2 Product Portfolio
5.2.3.3 Top Competitors
5.2.3.4 Target Customers
5.2.3.5 Key Personnel
5.2.3.6 Analyst View
5.2.4 Next Biosciences
5.2.4.1 Overview
5.2.4.2 Product Portfolio
5.2.4.3 Top Competitors
5.2.4.4 Target Customers
5.2.4.5 Key Personnel
5.2.4.6 Analyst View
6 Research Methodology
6.1 Data Sources
6.1.1 Primary Data Sources
6.1.2 Secondary Data Sources
6.1.3 Data Triangulation
6.2 Market Estimation and Forecast
List of Figures
Figure 1: Global Non-Invasive Prenatal Testing Market (by Region), $Million, 2022, 2026, and 2033
Figure 2: Prevalence of Genetic Disorders in Early Pregnancy, U.S., 2022
Figure 3: Global Non-Invasive Prenatal Testing Market (by Application), $Million, 2022, 2026, and 2033
Figure 4: Global Non-Invasive Prenatal Testing Market (by End User), $Million, 2022, 2026, and 2033
Figure 5: Global Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022, 2026, and 2033
Figure 6: Global Non-Invasive Prenatal Testing Market (by Method), $Million, 2022, 2026, and 2033
Figure 7: Global Non-Invasive Prenatal Testing Market, Recent Developments, 2023
Figure 8: Supply Chain of Global NIPT Market
Figure 9: Global NIPT Market, Patent Analysis, (by Country), January 2020-December 2023
Figure 10: Global NIPT Market, Patent Analysis, (by Year), January 2020-December 2023
Figure 11: Reimbursement Scenario in Major Countries of the Global NIPT Market
Figure 12: Impact Analysis of Market Navigating Factors, 2022-2033
Figure 13: Births with Trisomies per 100,000 Live Births in Europe Region, 2000-2021
Figure 14: Age of Mother at Childbirth over the Years
Figure 15: Reimbursement Scenario in Major Countries
Figure 16: Number of Tests Processed by Natera, Inc., 2018-2020
Figure 17: Positives from Data of 75,000 NIPT Tests Showing False Positives
Figure 18: Recent Developments in APAC by Key Companies
Figure 19: North America Non-Invasive Prenatal Testing Market, Thousand Unit, 2023-2033
Figure 20: North America Non-Invasive Prenatal Testing Market, $Million, 2023-2033
Figure 21: U.S. Non-Invasive Prenatal Testing Market, Thousand Unit, 2023-2033
Figure 22: U.S. Non-Invasive Prenatal Testing Market, $Million, 2022-2033
Figure 23: Canada Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033
Figure 24: Canada Non-Invasive Prenatal Testing Market, $Million, 2023-2033
Figure 25: Europe Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033
Figure 26: Europe Non-Invasive Prenatal Testing Market, $Million, 2023-2033
Figure 27: France Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033
Figure 28: France Non-Invasive Prenatal Testing Market, $Million, 2023-2033
Figure 29: Germany Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033
Figure 30: Germany Non-Invasive Prenatal Testing Market, $Million, 2023-2033
Figure 31: U.K. Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033
Figure 32: U.K. Non-Invasive Prenatal Testing Market, $Million, 2022-2033
Figure 33: Spain Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033
Figure 34: Spain Non-Invasive Prenatal Testing Market, $Million, 2022-2033
Figure 35: Italy Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033
Figure 36: Italy Non-Invasive Prenatal Testing Market, $Million, 2022-2033
Figure 37: Rest-of-Europe Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033
Figure 38: Rest-of-Europe Non-Invasive Prenatal Testing Market, $Million, 2022-2033
Figure 39: Asia-Pacific Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033
Figure 40: Asia-Pacific Non-Invasive Prenatal Testing Market, $Million, 2023-2033
Figure 41: China Non-Invasive Prenatal Testing Market, Thousand, 2023-2033
Figure 42: China Non-Invasive Prenatal Testing Market, $Million, 2022-2033
Figure 43: India Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033
Figure 44: India Non-Invasive Prenatal Testing Market, $Million, 2022-2033
Figure 45: Japan Non-Invasive Prenatal Testing Market, Thousand Units, 2022-2033
Figure 46: Japan Non-Invasive Prenatal Testing Market, $Million, 2022-2033
Figure 47: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market, Thousand Units, 2022-2033
Figure 48: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market, $Million, 2022-2033
Figure 49: Latin America Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033
Figure 50: Latin America Non-Invasive Prenatal Testing Market, $Million, 2023-2033
Figure 51: Brazil Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033
Figure 52: Brazil Non-Invasive Prenatal Testing Market, $Million, 2022-2033
Figure 53: Mexico Non-Invasive Prenatal Testing Market, Thousand Units, 2022-2033
Figure 54: Mexico Non-Invasive Prenatal Testing Market, $Million, 2022-2033
Figure 55: Rest-of-Latin America Non-Invasive Prenatal Testing Market, Thousand Units, 2022-2033
Figure 56: Rest-of-Latin America Non-Invasive Prenatal Testing Market, $Million, 2022-2033
Figure 57: Middle East and Africa Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033
Figure 58: Middle East and Africa Non-Invasive Prenatal Testing Market, $Million, 2023-2033
Figure 59: U.A.E. Non-Invasive Prenatal Testing Market, Thousand Units, 2022-2033
Figure 60: U.A.E. Non-Invasive Prenatal Testing Market, $Million, 2022-2033
Figure 61: South Africa Non-Invasive Prenatal Testing Market, Thousand Units, 2022-2033
Figure 62: South Africa Non-Invasive Prenatal Testing Market, $Million, 2022-2033
Figure 63: Rest-of-Middle East and Africa Non-Invasive Prenatal Testing Market, Thousand Units, 2022-2033
Figure 64: Rest-of-Middle East and Africa Non-Invasive Prenatal Testing Market, $Million, 2022-2033
Figure 65: Share of Strategic Initiatives
Figure 66: Data Triangulation
Figure 67: Top-Down and Bottom-Up
Figure 68: Assumptions and Limitations
List of Tables
Table 1: Market Snapshot
Table 2: Global Non-Invasive Prenatal Testing Market, Opportunities
Table 3: Market Share of Major Players
Table 4: Key Companies’ Partnerships and Alliances
Table 5: NIPT Tests in the NIPT Market and their Corresponding Applications
Table 6: Risk of Chromosomal Abnormality w.r.t Maternal Age
Table 7: Global Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 8: Global Non-Invasive Prenatal Testing Market (by Application), Thousand Units, 2022-2033
Table 9: Global Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 10: Global Non-Invasive Prenatal Testing Market (by End User), Thousand Units, 2022-2033
Table 11: Global Non-Invasive Prenatal Testing Market, by Test, $Million
Table 12: Global Non-Invasive Prenatal Testing Market, by Platform, $Million
Table 13: Global Non-Invasive Prenatal Testing Market, by Platform, Thousand Unit
Table 14: Global Non-Invasive Prenatal Testing Market, by Method, $Million
Table 15: Global Non-Invasive Prenatal Testing Market, by Method, Thousand Unit
Table 16: Global Non-Invasive Prenatal Testing Market (by Region), Thousands Units, 2022-2033
Table 17: Global Non-Invasive Prenatal Testing Market (by Region), $Million, 2022-2033
Table 18: North America Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 19: North America Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 20: North America Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
Table 21: North America Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
Table 22: U.S. Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 23: U.S. Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 24: U.S. Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
Table 25: U.S. Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
Table 26: Canada Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 27: Canada Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 28: Canada Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
Table 29: Canada Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
Table 30: Europe Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 31: Europe Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 32: Europe Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
Table 33: Europe Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
Table 34: France Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 35: France Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 36: France Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
Table 37: France Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
Table 38: Germany Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 39: Germany Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 40: Germany Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
Table 41: Germany Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
Table 42: U.K. Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 43: U.K. Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 44: U.K. Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
Table 45: U.K. Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
Table 46: Spain Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 47: Spain Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 48: Spain Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
Table 49: Spain Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
Table 50: Italy Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 51: Italy Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 52: Italy Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
Table 53: Italy Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
Table 54: Rest-of-Europe Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 55: Rest-of-Europe Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 56: Rest-of-Europe Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
Table 57: Rest-of-Europe Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
Table 58: Asia-Pacific Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 59: Asia-Pacific Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 60: Asia-Pacific Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
Table 61: Asia-Pacific Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
Table 62: China Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 63: China Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 64: China Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
Table 65: China Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
Table 66: India Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 67: India Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 68: India Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
Table 69: India Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
Table 70: Japan Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 71: Japan Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 72: Japan Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
Table 73: Japan Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
Table 74: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 75: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 76: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
Table 77: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
Table 78: Latin America Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 79: Latin America Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 80: Latin America Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
Table 81: Latin America Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
Table 82: Brazil Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 83: Brazil Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 84: Brazil Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
Table 85: Brazil Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
Table 86: Mexico Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 87: Mexico Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 88: Mexico Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
Table 89: Mexico Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
Table 90: Rest-of-Latin America Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 91: Rest-of-Latin America Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 92: Rest-of-Latin America Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
Table 93: Rest-of-Latin America Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
Table 94: Middle East and Africa Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 95: Middle East and Africa Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 96: Middle East and Africa Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
Table 97: Middle East and Africa Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
Table 98: U.A.E. Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 99: U.A.E. Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 100: U.A.E. Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
Table 101: U.A.E. Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
Table 102: South Africa Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 103: South Africa Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 104: South Africa Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
Table 105: South Africa Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
Table 106: Rest-of-Middle East and Africa Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
Table 107: Rest-of-Middle East and Africa Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
Table 108: Rest-of-Middle East and Africa Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
Table 109: Rest-of-Middle East and Africa Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
Table 110: Market Share (2022)